Hanson & Doremus Investment Management’s iShares 1-3 Year Treasury Bond ETF SHY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Hold
226
﹤0.01% 393
2026
Q1
$19K Hold
226
﹤0.01% 416
2025
Q4
$19K Hold
226
﹤0.01% 396
2025
Q3
$19K Hold
226
﹤0.01% 399
2025
Q2
$19K Hold
226
﹤0.01% 401
2025
Q1
$19K Buy
+226
New +$18.6K ﹤0.01% 394
2018
Q3
Sell
-816
Closed -$68K 484
2018
Q2
$68K Hold
816
0.02% 264
2018
Q1
$68K Hold
816
0.02% 271
2017
Q4
$68K Hold
816
0.02% 266
2017
Q3
$69K Hold
816
0.02% 259
2017
Q2
$69K Hold
816
0.03% 255
2017
Q1
$69K Sell
816
-94
-10% -$7.94K 0.03% 252
2016
Q4
$76.8K Buy
+910
New +$77K 0.03% 233

Other funds holding SHY

Hanson & Doremus Investment Management's SHY Position: Q2 2026 in Review

Hanson & Doremus Investment Management held its iShares 1-3 Year Treasury Bond ETF (SHY) position steady in Q2 2026 at 226 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Hanson & Doremus Investment Management first reported a position in SHY in Q4 2016 and has held it in 13 quarters since. The position peaked at $76.8K in Q4 2016. 506 funds tracked by Wall St. Rank hold SHY as of Q2 2026.

  • Hanson & Doremus Investment Management held 226 shares of iShares 1-3 Year Treasury Bond ETF worth $19K as of Q2 2026.
  • Hanson & Doremus Investment Management left its iShares 1-3 Year Treasury Bond ETF share count unchanged in Q2 2026.
  • iShares 1-3 Year Treasury Bond ETF made up ﹤0.01% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #393 holding.
  • Hanson & Doremus Investment Management first reported a position in iShares 1-3 Year Treasury Bond ETF in Q4 2016 and has held it in 13 quarters since.
  • Hanson & Doremus Investment Management's iShares 1-3 Year Treasury Bond ETF position peaked at $76.8K in Q4 2016.
  • 506 funds tracked by Wall St. Rank held iShares 1-3 Year Treasury Bond ETF as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.